SCHEMBL3546148

SCHEMBL3546148

CC(=O)Nc1cc2c3c(c1)c1c(n3CCC2=O)CCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.40
APP P05067 1/20 0.40
BCHE P06276 1/20 0.40
BAZ2B Q9UIF8 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTR2C P28335 3/20 0.36
HTR2A P28223 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
GFER P55789 1/20 0.35
GAA P10253 1/20 0.34
BRD4 O60885 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3545321 0.81 HTR2C (0.43) ACHEAPPBCHEBAZ2BKDM4E
SCHEMBL6968736 0.76 HTR2C (0.39) ACHEBCHEKDM4EALDH1A1HSD17B10
SCHEMBL6983000 0.73 HTR2C (0.39) KDM4EALDH1A1HPGDHSD17B10HTR2C
SCHEMBL3551076 0.72 CNR2 (0.41) KDM4EHSD17B10HTR2CHTR2AMEN1
SCHEMBL3542640 0.70 HTR2A (0.38) HTR2CHTR2AGAALMNA
SCHEMBL3543857 0.70 RORC (0.41) KDM4EALDH1A1HTR2CHTR2AMEN1
SCHEMBL3546317 0.70 HTR2C (0.40) ACHEBCHEKDM4EALDH1A1HPGD
SCHEMBL3540288 0.70 RAB9A (0.39) ACHEBCHEKDM4EALDH1A1HPGD
SCHEMBL3541848 0.69 MAPT (0.40) ACHEBCHEKDM4EALDH1A1HTR2C
SCHEMBL3546473 0.68 RORC (0.41) KDM4EALDH1A1HTR2CHTR2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662831-B2 Tetracyclic indoles as potassium channel modulators WYETH LLC (US) 2010-02-16 US claimed
US-20080027090-A1 TETRACYCLIC INDOLES AS POTASSIUM CHANNEL MODULATORS WYETH (US) 2008-01-31 US claimed
US-7662831-B2 Tetracyclic indoles as potassium channel modulators WYETH LLC (US) 2010-02-16 US disclosed
US-20080027090-A1 TETRACYCLIC INDOLES AS POTASSIUM CHANNEL MODULATORS WYETH (US) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027090-A1 TETRACYCLIC INDOLES AS POTASSIUM CHANNEL MODULATORS KCNJ2, KCNA5, KCNK5 ACHE 869/4885APP 2024/4885BCHE 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.